Measuring IgG levels and B cell counts may identify high infection risk and help clinicians balance the risk of immunosuppression side effects and disease activity in patients with systemic vasculitis.
Study assesses long-term outcomes associated with Churg-Strauss syndrome and provides insights on how to better care for these patients.
Takayasu arteritis (TA) can manifest in childhood and the symptoms may be overlooked, leading to delay in diagnosis and poor outcomes. A study that included 40 children with TA provides insights on the diagnosis and treatment of this rare and potentially life-threatening condition.
Persistent lupus anticoagulant positivity in patients with antineutrophil cytoplasmic antibody-associated vasculitis is associated with higher Vasculitis Damage Index scores.
Researchers in this study sought to describe distinct histological subtypes of temporal artery biopsies.
This is the first randomized placebo-controlled trial to demonstrate the induction and remission efficacy of IL-6 inhibition with tocilizumab in patients with giant cell arteritis (GCA).
Research suggests that patients with giant cell arteritis have an increased risk of infection during the first year following diagnosis.
